Stock Scorecard
Stock Summary for Protagenic Therapeutics Inc (PTIX)
Total Score
11 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for PTIX
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for PTIX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for PTIX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 |
Bonus Criteria for PTIX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Financial Details for PTIX
Company Overview |
|
|---|---|
| Company Name | Protagenic Therapeutics Inc |
| Country | USA |
| Description | Protagenic Therapeutics, Inc., a preclinical biopharmaceutical company, is dedicated to the discovery and development of therapies to treat stress-related mood and neuropsychiatric disorders. The company is headquartered in New York, New York. |
| Sector Name | TRADE & SERVICES |
| Industry Name | SERVICES-BUSINESS SERVICES, NEC |
| Most Recent Quarter | 9/30/2022 |
| Next Earnings Date | |
Stock Price History |
|
| Last Day Price | 0.53 |
| Last Day Volume | 18,328 |
| Average Daily Volume | 36,645 |
| 52-Week High | 1.89 |
| 52-Week Low | 0.52 |
| Last Price to 52 Week Low | 1.92 % |
Valuation Measures |
|
| Trailing PE | 0.00 |
| Industry PE | 119.02 |
| Sector PE | 74.05 |
| 5-Year Average PE | -5.72 |
| Free Cash Flow Ratio | 1.13 |
| Industry Free Cash Flow Ratio | 36.98 |
| Sector Free Cash Flow Ratio | 57.06 |
| Book Value Per Share Most Recent Quarter | 0.43 |
| Price to Book Ratio | 1.25 |
| Industry Price to Book Ratio | 6.55 |
| Sector Price to Book Ratio | 7.86 |
| Price to Sales Ratio Twelve Trailing Months | 0.00 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.46 |
| Sector Price to Sales Ratio Twelve Trailing Months | 1.91 |
Share Statistics |
|
| Total Shares Outstanding | 17,285,300 |
| Market Capitalization | 9,161,209 |
| Institutional Ownership | 0.00 % |
Dividends |
|
| Ex-Dividend Date | |
| Last Dividend Amount | 0.00 |
| Current Dividend Amount | 0.00 |
| Dividend Aristocrat? | False |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00 % |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00 % |
| 5-Year Average Dividend Yield | 0.00 % |
| 5-Year Dividend Payments Count | 0 |
| Dividend Payout Ratio | 0.00 % |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00 % |
| Annual Earnings Growth | -77.46 % |
| Reported EPS Past Year | -0.14 |
| Reported EPS Prior Year | -0.32 |
| Net Income Twelve Trailing Months | -3,844,518 |
| Net Income Past Year | -4,522,934 |
| Net Income Prior Year | -2,548,735 |
| Quarterly Revenue Growth YOY | 0.00 % |
| 5-Year Revenue Growth | -100.00 % |
Balance Sheet |
|
| Total Cash Per Share | 0.47 |
| Total Cash Most Recent Quarter | 8,152,713 |
| Total Cash Past Year | 8,868,282 |
| Total Cash Prior Year | 10,371,256 |
| Net Cash Position Most Recent Quarter | 8,025,688 |
| Net Cash Position Past Year | 8,764,824 |
| Long Term Debt Past Year | 103,458 |
| Long Term Debt Prior Year | 132,284 |
| Total Debt Most Recent Quarter | 127,025 |
| Equity to Debt Ratio Past Year | 0.99 |
| Equity to Debt Ratio Most Recent Quarter | 0.98 |
| Current Ratio Most Recent Quarter | 14.91 |
| Total Stockholder Equity Past Year | 8,258,098 |
| Total Stockholder Equity Prior Year | 9,941,955 |
| Total Stockholder Equity Most Recent Quarter | 7,382,040 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | False |
| Liquidity Rating | None |
Technical Analysis |
|
| MACD | -0.01 |
| MACD Signal | -0.02 |
| 20-Day Bollinger Lower Band | 0.52 |
| 20-Day Bollinger Middle Band | 0.62 |
| 20-Day Bollinger Upper Band | 0.73 |
| Beta | -0.09 |
| RSI | 54.15 |
| 50-Day SMA | 0.83 |
| 200-Day SMA | 1.73 |
System |
|
| Modified | 12/3/2022 11:27:20 PM |